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SUPPLEMENTARY MATERIAL 
“Melusin protects from cardiac rupture and improves functional remodelling in mice after 
myocardial infarction” 
Bernhard Unsöld et al. 
 
Matherial and Methods 
Induction of Myocardial infarction 
Mice weighing 20±2 g (females) and 25±2 g (males) aged 7-8 weeks were anaesthetised by 
isoflurane inhalation and endotracheally intubated. Anaesthesia was maintained by 
continuous inhalation of 1.5 % isoflurane in room air. They were placed in a right lateral 
decubitus position and the fur was removed from the left hemithorax by use of depilatory 
cream. A left lateral thoracotomy was performed to expose the heart. Following 
pericardiotomy the LAD was visualized and ligated with a 9-0 prolene suture with an 
atraumatic needle. Successful ligation was confirmed by bleaching and hypokinesis of the 
perfused myocardium. Following expansion of the lungs by compression of the exhalation 
tube the thorax and the skin were closed with separate single 6-0 prolene sutures. Isoflurane 
inhalation was stopped and the mice were ventilated until they breathed spontaneously. 
They were kept separate on a warming plate until fully awake. Postoperative analgesia was 
provided by metamizole added to the drinking water (1.33 mg/ml) for 7 days. The sham 
operation was performed similarly however no coronary artery ligation was performed. 
 
Determination of myocardium at risk 
The volume of myocardium at risk was determined in a subset of animals by retrograde 
coronary perfusion with Evan’s blue (1%) 3-4 hours after coronary ligation. The perfused 
myocardium stained by Evan’s blue was dissected from the non stained ischemic 
myocardium under a microscope and the weight of both portions was determined.  
 
Measurement of infarct size 
Paraffin-embedded tissues of animals sacrificed 3 days after surgery were cut in 5 µm 
sections beginning 900 µm from the apex of each heart to be safely within the infracted 
tissue. Haematoxylin/eosin stained tissues were used for the calculation of the infarct size of 
the heart using the area measurement method
1
. Infarct size was defined as the sum of the 
epicardial and endocardial infarct circumference divided by the sum of the total LV epicardial 
and endocardial circumferences using computer based planimetry. Quantitative assessments 
were performed with image analysis software AxioVision Rel.4.7 (Carl Zeiss). 
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Measurements of cell contraction and Ca
2+ 
transients 3 days after MI 
As these measurements were performed at Leuven/Belgium these 24 mice were the only 
ones not operated at the central site in Goettingen. However the operations were 
performed by one operator according to the standard operational procedure established in 
Goettingen. Mice were sacrificed 72 hours after LAD ligation and single cardiac myocytes 
were isolated as described previously
2
. Briefly, mice received an IP injection of pentobarbital 
and heparin and hearts were quickly removed through a thoracotomy under full 
anaesthesia. The aorta was cannulated on a Langendorff setup for retrograde perfusion with 
an enzyme solution (collagenase B, Roche, and protease XIV, Sigma). After digestion, single 
cells were dispersed from the viable LV myocardium (RV, MI scar and the border zone were 
discarded). Measurements of contraction and intracellular calcium concentration [Ca
2+
]i 
were performed as described previously
2
. Briefly, cell shortening was measured using edge 
tracking (Ionoptix) during electrical field stimulation at 1 Hz; action potentials and [Ca
2+
]i 
were measured during whole-cell patch clamp with fluo-3 as indicator loaded via the patch 
pipette. During field stimulation and patch-clamp experiments cells were superfused with 
normal Tyrode solution (in mmol/l: 137 NaCl, 5.4 KCl, 0.5 MgCl2, 1 CaCl2, 11.8 HEPES and 10 
glucose, pH was adjusted to 7.40 with NaOH). The pipette solution for whole-cell patch 
clamp contained (in mmol/l): 120 K-aspartate, 20 KCl, 10 NaCl, 10 K-HEPES, 5 MgATP, and 




Measurements of cell contraction and Ca
2+
 transients 14 days after MI 
Shortening and Ca
2+
 measurements were performed using an IonOptix fluorescence and 
Myocam setup (IonOptix, Milton/USA) mounted to a Nikon Eclipse TE300 microscope as 
described previously
3
. Single cardiac myocytes were isolated using digestion with Liberase 
Blendzyme (Roche) and were loaded with the acetoxymethyl ester form of Fluo-3 (10μmol/l, 
Molecular Probes, Eugene/USA) by incubation for 15 minutes at room temperature. Emitted 
fluorescence was collected using a photomultiplier at ≈535±20nm and Ca
2+
 transient 
amplitudes were estimated by calculating peak fluorescence divided through baseline 
fluorescence (F/F0) after subtracting background fluorescence. Myocyte shortening was 
assessed by measuring sarcomere length and percentual myocyte fractional shortening was 
calculated from this measurement. 
 
Immunohistochemistry for CD18, CD31 and WGA staining 
Histochemical analyses were performed on 5 µm-thick frozen cross sections through the left 
ventricle. For each mouse, 4 sections, approximately 500 µm apart, were analyzed and 
findings averaged. For immunohistochemical analyses rat monoclonal antibody against CD18 
(BMA, Augst, Switzerland) was used according to manufacturer instructions. Biotinylated 
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rabbit anti-rat IgG (Dako Cytomation, Milano, Italy) was used as the secondary antibody. 
Immunoreactivity was detected with the streptABCComplex/HRP system (DakoCytomation; 
Milano, Italy) and developed with DAB (methanol 3,3 diamino-benzide, Roche Diagnostic 
Corp., Milano, Italy). Monoclonal rat anti-mouse antibodies against CD31 were used to 
detect endothelial cells (sc-18916; dilution, 1:40; SantaCruz Biotechnology). After incubation 
overnight at 4°C and subsequent washing in phosphate-buffered saline (PBS), phycoerythrin 
(PE)-labeled secondary goat anti-rat antibody (dilution, 1:400; Molecular Probes) was added, 
followed by incubation with fluorescein (FITC)-labeled wheat germ agglutinin (WGA; dilution, 
1:200; Molecular Probes) in order to delineate cardiomyocytes and 4',6-diamidino-2-
phenylindole (DAPI; dilution, 1:500; Sigma) to visualize cell nuclei. Sections were mounted in 
VectaShield (Vector) and inspected on a Zeiss axiovert fluorescence microscope. The number 
of CD31-positive endothelial cells was evaluated on 4 randomly selected microscope fields 
(400x magnification) per section and expressed per mm² or cardiomyocyte fiber. The 
cardiomyocyte cross sectional area (CSA) was determined after WGA staining using 
specialized image analysis software (Image ProPlus). 
 
Phospho-ERK1/2 immunohistochemistry 
Tissue sections (4 µm) were cut from formalin fixed, paraffin embedded hearts from wild 
type and melusin transgenic mice 3 days after MI. For p-ERK1/2 staining (antibody from Cell 
Signaling) manufacturer's instructions were followed. Briefly, sections were de-waxed and 
rehydrated and antigen was retrieved incubating the glass slides in sodium citrate for 10 
minutes at sub boiling temperature in a microwave oven. Sections were incubated with anti-
p-ERK1/2 antibodies (1:100) overnight at 4°C. Biotinylated secondary anti-rabbit antibodies 
(1:200) were left on the sections for 30 min at RT. Immunostaining was performed using 
avidin-biotin-HRP system with diaminobenzidine as chromogen. Sections were not 
counterstained. For the analysis of p-ERK1/2 positive nuclei, pictures were taken at 400X 
magnification, using the same light intensity, from specific regions of the sections, as 
indicated in the results. Images were analysed using Image J software, without any 
brightness/contrast manipulation. To count the number of p-ERK positive nuclei, a 
comparable threshold level was set for all images analysed, to highlight only stained nuclei. 
Using the Analyze Particles tool, the highlighted nuclei were counted, excluding particles 
with an area outside the size range of cardiomyocyte nuclei (to exclude non-cardiomyocyte 
nuclei and non-nuclei spots from the count).  
 
Detection of Apoptosis 
Apoptotic cells were detected by TUNEL using the In Situ Detection Kit, Fluorescein (Roche, 
Almere, Netherlands) according to the manufacturer’s instructions. Briefly, paraffin sections 
(5 μm) were pre-treated with Proteinase K (20 μg/ml in PBS, Roche) for 15 min at RT. 
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Subsequently, sections were incubated with 3% BSA and 20% fetal bovine serum in PBS (30 
min, RT) to reduce background. Sections were incubated in a dark, humidified chamber with 
the TUNEL reaction mixture (60 min, 37°C). After washing (3x with PBS) sections were 
mounted in Vectashield mounting medium with DAPI (Vector Laboratories, Burlingame, 
U.S.). Sections were analysed by fluorescent microscopy (Leica DM5000B; Leica 
Microsystems, Rijswijk, Netherlands) using the Leica Qwin software program. Apoptosis was 
quantified by analysing 3 pictures of the non-infarcted septum on 2 sections per heart, 
generating a median value for each animal. Data are expressed as the percentage of TUNEL-
positive cells over DAPI stained nuclei for each group. 
 
Sirius Red staining 
Sirius Red staining of paraffin embedded cross sections was used for fibrosis calculation. Ten 
microscopic pictures in 10-fold magnification were taken from one slide of each animal and 
analysed by the image-processing software ImageJ (shareware from the NIH). After manually 
setting a threshold using a randomly chosen subset of the pictures, we measured the 
relationship of Sirius red-stained area (connective tissue in red) to total area of the picture 
and calculated the percentage of connective tissue. 
 
RNA isolation and real-time quantitative PCR for cytokines and growth factors 3 days after 
MI 
RNA was extracted from frozen heart tissue using Trizol (Invitrogen). 1 µg of total RNA was 
retro-transcribed to cDNA using a high capacity cDNA reverse transcription kit (Applied 
Biosystems). Singleplex TaqMan real time PCR was performed using the Roche Universal 
Probe Library system in combination with specific primers indicated in supplementary Table 
1. 18S rRNA expression was measured to normalize gene expression using TaqMan Applied 
Biosystems Eukaryotic 18S rRNA Endogenous Control assay. PCRs were run on an Applied 
Biosystems 7900HT system and results were analyzed with the provided software. 
 
RNA isolation and real-time quantitative PCR for metabolic enzymes 2 weeks after MI 
Total RNA was isolated with TRI reagent (Sigma, St Louis, MO, USA) according to the 
manufacturer’s protocol and complemented with an additional wash step of 70% ethanol to 
increase the purity of the RNA. Integrity of the RNA was checked by means of the 260/280 
nm ratio. 250 ng of RNA was treated with DNase type I (Sigma) and subsequently used for 
cDNA synthesis (Iscript cDNA synthesis kit, Bio-Rad Inc., Hercules, CA, USA). QPCR assays 
were performed on a MyiQ Single-Color Real-Time PCR Detection System (Bio-Rad) using the 
iQ SYBR-Green supermix (Biorad). qPCR was performed for the nuclear peroxisome 
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proliferator-activated receptor alpha (Pparα), its co-activator protein peroxisome 
proliferator-activated receptor gamma coactivator 1-alpha (Ppargc1α) as well as for the 
long-chain-fatty-acid-CoA ligase 1 (Acsl1) and the mitochondrial trifunctional enzyme subunit 
alpha (Hadha), two enzymes involved in fatty acid metabolism. Primer sequences are given 
in supplementary Table 1. For all primer sets, temperature and dilution curves were assessed 
to check for linearity. Expression levels were normalized to the housekeeping gene 
cyclophilin A (Ppia). Relative changes in expression were calculated using GeneX software 
(Bio-Rad). The values were normalized for the value of sham operated female wild type mice 
for which the group average was arbitrarily set to 1. 
 
RNA isolation and real-time quantitative PCR for ANF 
For the measurement of Nppa quantitative real-time RT-PCR was performed using the 
standard curve method with the Taqman instrument (ABI7000) and SYBR green. Experiments 
were performed in duplicates. mRNA content was normalized to the mRNA content of 
Gapdh in the same sample. Primers sequences are given in supplementary Table 1. 
 
Western blotting 
Calcium handling proteins 
Western blotting was performed as described previously
4
. In brief, protein content in the 
samples was determined and similar amounts of total protein per sample were loaded. 
Primary antibodies against calsequestrin (Dianova, Hamburg, Germany), total 
phospholamban (PLB), Thr
17
-phosphorylated PLB and Ser
16
-phosphorylated PLB (Badrilla, 
Leeds, UK), troponin-I (Tn-I, Chemicon, Dundee, Scotland), Ser
22/23
-phosphorylated Tn-I (Cell 
Signaling Technology, Boston, MA, USA), SR-Ca
2+
-ATPase (SERCA2a, Santa Cruz, California, 
USA). Antibody binding was detected by horseradish peroxidase-conjugated secondary 
antibodies. The values were normalized for the value of sham operated female wild type 
mice for which the group average was arbitrarily set to 1. 
Melusin and HSP70 
Frozen heart extracts were reconstituted in cold lysis buffer containing phosphatase and 
protease inhibitors (composition in mmol/l: imidazole, 50, pH 7.0; KCl, 300; NaF, 10; EGTA, 1; 
MgCl2, 0.5; β-glycerophosphate, 10; NaVO4, 1; dithiothreitol, 1; phenylmethylsulfonyl 
fluoride, 0.1; and benzamidine, 1) and homogenized by sonication on ice. Equal amounts of 
denatured proteins were separated by 10-8 % acrylamide gel electrophoresis, transferred to 
nitrocellulose or polyvinylidene difluoride membranes, blocked overnight in 0.1 % Tris-
buffered saline/Tween-20 buffer containing 5 % (wt/vol) nonfat dry milk (Fluka) or albumin 
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according to the manufacturer’s protocol and analyzed with primary antibodies to melusin 
and HSP70. Vinculin was used as loading control). 
Vinculin antibody was from Sigma, St. Louis, MO, USA and HSP70 antibody was from 
Stressgen, Victoria, British Columbia, Canada. The antibody used to detect melusin was 
custom made
5
. Horseradish peroxidase-conjugated secondary antibodies were used 
according to the manufacturer’s instruction. Protein bands were visualized using ECL reagent 
(Perkin Elmer, Boston, USA) and detected using Kodak film or Geliance 600, Perkin Elmer. 
Band intensity was quantified by densitometry of immunoblots using ImageJ program. 
Results of densitometric analyses were expressed as ratios to loading control.  
 
SUPPLEMENTARY TABLE 1 
Gene Forward primer Reverse primer 
Acsl1 GAGGGTGAGGTGTGTGTGAA CAGCTGTTCTTGCTGGGTCT 





Col1α1 CATGTTCAGCTTTGTGGACCT GCAGCTGACTTCAGGGATGT 






Gapdh ATGGTGAAGGTCGGTGTGA AATCTCCACTTTGCCACTGC 
Gdf15  
GAGCTACGGGGTCGCTTC GGGACCCCAATCTCACCT 
Hadha GGTGTCCCTGAAGTGTTGCT TCTGTCTGCACGAATGTTCC 
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Il1b   
AGTTGACGGACCCCAAAAG GAAGCTGGATGCTCTCATCA 






Marco  GGCACCAAGGGAGACAAA TCCCTTCATGCCCATGTC 
Myh6 CGCATCAAGGAGCTCACC CCTGCAGCCGCATTAAGT 
Myh7  
CGCATCAAGGAGCTCACC CTGCAGCCGCAGTAGGTT 
Nppa (2 weeks) CCTGTGTACAGTGCGGTGTC CCTCATCTTCTACCGGCATC 
Pgf  CTGGGTTGGCTGTGCATT GGCACCACTTCCACTTCTGT 
Pparα TATTCGGCTGAAGCTGGTGTAC CTGGCATTTGTTCCGGTTCT 
Ppargc1α TTGAGGAATGCACCGTAAATC GCTCGAAGTCAGTTTCATTCG 
Retnla CCCTCCACTGTAACGAAGACTC CACACCCAGTAGCAGTCATCC 








Gene   full name 
Acsl1   Long-chain-fatty-acid—CoA ligase 1  
Acta2  actin, alpha 2, smooth muscle, aorta 
Ccl2  chemokine (C-C motif) ligand 2 
Ccl3  chemokine (C-C motif) ligand 3 
Col1α1  collagen, type I, alpha 1 
Cxcl10  chemokine (C-X-C motif) ligand 10 
Cxcl2  chemokine (C-X-C motif) ligand 2 
Eno1   enolase 1 
Eno3   enolase 3 
Fn1  fibronectin 1 
Gdf15  growth differentiation factor 15 
Glut1   glucose transporter member 1 
Glut4   glucose transporter member 4 
Hadha  hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase 
Ifnγ  interferon gamma 
Igf1  insulin-like growth factor 1 
Il10  interleukin 10 
Il18  interleukin 18 
Il1β  interleukin 1 beta 
Il6  interleukin 6 
Itgam  integrin alpha M 
Klf5  Kruppel-like factor 5 
Marco  macrophage receptor with collagenous structure 
Mmp9  matrix metallopeptidase 9 
Myh6  myosin, heavy polypeptide 6, cardiac muscle, alpha 
Myh7  Myh7 and Name: myosin, heavy polypeptide 7, cardiac muscle, beta 
Pgf  placental growth factor 
Ppargc1α  Peroxisome proliferator-activated receptor gamma coactivator 1-alpha   
Pparα   peroxisome proliferator-activated receptor alpha 
Pparδ   peroxisome proliferator-activated receptor delta 
Pparγ   peroxisome proliferator-activated receptor gamma 
Retnla  resistin like alpha 
Tgfβ1  transforming growth factor, beta 1 
Tmsb4x  thymosin, beta 4, X chromosome 
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Tnf  tumor necrosis factor 
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mRNA expression of hypertrophic markers, cytokines and growth factors 3 days 
after MI. 





















































































































































mRNA expression of metabolic enzymes 3 days after MI. 





































































Western blot analysis of phosphorylated phospholamban and calsequestrin 12 
days after MI. 
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